Educational research & price index · Independent Janoshik & MZ Biolabs COA verification

← Verified COAs & $/mg for this compound

Guide|3 CitationsGLP-1 & MetabolicFemale-friendly

Retatrutide Research Dosing Reference

Also known as: LY3437943, Triple Agonist (GLP-1/GIP/GCGR), Reta

Dose Range
1–8 mgResearch range
0Typical research window: 1–8 mg12 mg

Studied in NEJM Phase 2 human trials (Jastreboff et al., PMID: 37366315). Subjects started at 1–2 mg once weekly and titrated every 4 weeks.

Protocol at a Glance
How Often
Once weekly

Once every 7 days SubQ (titrated gradually every 4 weeks)

A Typical Run
12–48 weeks

Phase 2/3 trials titrate from 1–2 mg/wk up to 4–8 mg/wk (max 12 mg/wk) over 24–48 weeks.

How It's Taken
Vial

SubQ injection once weekly

Evidence
Clinical Trials

NEJM Phase 2 RCTs & ongoing TRIUMPH Phase 3 human trials

Half-Life & 72-Hour Clearance Shape
~6 days

~6 days (~144 hours) terminal half-life enabling steady once-weekly dosing

0h18h36h54h72h
On Your SyringeU-100 Insulin Syringe

A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.

10 mg vial · 2 mL water · 0.5 mL syringe
Concentration: 5 mg in every mL (50 mcg per unit)
0u10u20u30u40u50u
Low end: 1 mg20 units
High end: 8 mg160 units

All U-100: 100 units = 1 mL. 10 doses in the vial at the low end (1 doses at the high end).

Track the doses you run

Save Retatrutide to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.

Verified Peptide Vial Suppliers · Sorted by Real $/mg•Checked Nov 11, 2026

Retatrutide supplier & $/mg comparison.

Source:
Max $/mg:
Sort:
Elite Research USA
Batch COA on product page
US Domestic Vial
List price
$225.00
60mg vial, sold as “ER-RT”
$3.75/mg
Ascension Peptides50% OFF AUTO-APPLIED
Batch COAs (Kovera Labs, MZ Biolabs) on product page
US Domestic Vial
50% Off First Order Link
$125.00 net$250.00
30mg vial, sold as “R-30”
$4.17/mg$8.33/mg retail
Peptyes
Horizon Analytical UPLC-MS COA, lot DPS-6386094 (99.83%); COA names Privilege Bio Labs (Peptyes says: its manufacturer)
US Domestic Vial
List price (verified Nov 11, 2026); code PEPTIDEPROTOCOLS takes 10% off at checkout
$150.00
30mg vial, sold as “GLP-3 (R)” (vendor code name; compound per COA identity result)
$5.00/mg
Protide Health
Per-lot COA (Freedom Diagnostics, HPLC-MS) on product page
US Domestic Vial
List price
$550.00
100mg vial, sold as “GLP-3”
$5.50/mg
Bulletproof BioLabs
ILS Laboratories HPLC COA COA-2026-RY32YE, lot BPB-2610-001
US Domestic Vial
Vendor-supplied list price (Nov 7, 2026; store requires login)
$115.00
20mg vial, sold as “GLP-3 R” (vendor code name; compound mapping confirmed by vendor)
$5.75/mg
Direct Peptides
COA per store product page
US Domestic Vial
List price (last verified Nov 4, 2026; store now requires sign-in)
$189.00
30mg DP3-R
$6.30/mg
Polaris Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$400.00
60mg vial
$6.67/mg
Sorted strictly by calculated $/mg or 2026 COA score. Only research peptide vial suppliers are included in $/mg benchmarks.
Full Verified $/mg Index →

At a Glance · 2026 FDA / 503A / WADA / Evidence Profile

Phase 2/3 Clinical TrialsTier 1 — Human Phase 3 RCT / Approved
Pharmacological Class
Triple Hormone Receptor Agonist (GLP-1R + GIPR + Glucagon Receptor)
Administration Route
Under-the-skin injection (Subcutaneous)
2026 FDA & 503A Status
Active Phase 2/3 human clinical trials in 2026; not yet FDA-approved for commercial prescription or 503A bulk pharmacy compounding. Sold strictly as an analytical laboratory reference standard.
WADA Sport Status
Prohibited at All Times (WADA S0 Unapproved Substances & S2.2 Peptide Hormones, Growth Factors & Mimetics)
Evidence Tier
Tier 1 — Human Phase 3 RCT / Approved: Multi-center randomized controlled human clinical trials (Phase 3) and/or regulatory approval
What is a GLP-1 Agonist?

A molecule that mimics glucagon-like peptide-1 (GLP-1), a hormone that regulates blood sugar, slows gastric emptying, and reduces appetite. Semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) are GLP-1 agonists. These are peptides, but they are marketed and prescribed as pharmaceutical drugs.

EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Retatrutide is not FDA approved for human use (unless specified above). This information does not constitute medical advice.

Overview

Retatrutide is a triple hormone receptor agonist developed by Eli Lilly. It simultaneously activates GLP-1, GIP, and glucagon receptors — the first of its kind. Phase 2 trials showed unprecedented weight loss results (up to 24% of body weight), making it the most effective obesity medication in development.

Mechanisms of Action

  • Activates GLP-1 receptor — appetite suppression, glucose control
  • Activates GIP receptor — enhanced insulin secretion, fat metabolism
  • Activates glucagon receptor — increased energy expenditure, fat oxidation
  • Triple mechanism produces synergistic weight loss effects

Research Protocols

Summaries of published research. For educational purposes only.

Protocol NameSourceDoseFrequencyDurationRouteEvidenceLinkSave
Phase 2 Trial Protocol
clinical trial
1-12 mg (escalating)Once weekly48 weeksSubcutaneousclinical trial
Baseline & Mid-Cycle Biomarker Bloodwork Panel

Metabolic, Hepatic & Incretin Safety Biomarker Panel (Retatrutide)

Quantify visceral fat mobilization, insulin resistance reversal, hepatic steatosis (MASH) clearance, and pancreatic/renal safety during metabolic protocols.

Draw fasted morning labs at Baseline (Day 0) and Mid-Cycle (Week 6–8)

HbA1c & Fasting Insulin (HOMA-IR)

Day 0 + Wk 6–8

Why track at baseline: Measures baseline hyperinsulinemia and 90-day glycemic load prior to incretin or lipolytic initiation.

Week 6–8 check: Track rapid drop in Fasting Insulin (often 30%–50% reduction by Week 6–8) and normalizing HbA1c.

ALT, AST & GGT Liver Enzymes

Day 0 + Wk 6–8

Why track at baseline: Dual/triple agonists (Retatrutide, Mazdutide, Pemvidutide) mobilize 65%–80% of intrahepatic triglycerides.

Week 6–8 check: Confirm progressive reduction in ALT/AST (<25 U/L) as hepatic steatosis clears.

ApoB, Triglycerides & Advanced Lipid Panel

Day 0 + Wk 6–8

Why track at baseline: Quantifies atherogenic particle burden and VLDL triglyceride export before weight loss.

Week 6–8 check: Expect 20%–40% triglyceride drop and significant ApoB improvement alongside visceral fat loss.

Serum Lipase, Amylase & eGFR / Cystatin C

Day 0 + Wk 6–8

Why track at baseline: Essential safety screen for subclinical pancreatic inflammation and hydration/renal filtration.

Week 6–8 check: Ensure Lipase stays within reference range and eGFR remains stable with adequate electrolyte hydration.

Test before and during your protocol: one baseline panel of 100+ Quest biomarkers covering the markers above, plus a mid-cycle retest. No doctor visit required.Code SPAMBASSADOR
Get baseline bloodwork at Superpower

Related Studies

1 Human

Phase 2 trial of retatrutide in adults with obesity showed dose-dependent weight loss up to 24.2% at 48 weeks with the 12mg dose. The triple agonist (GLP-1/GIP/glucagon) demonstrated unprecedented efficacy for obesity treatment.

Limitations: Phase 2 only — Phase 3 trials ongoing; longer-term safety data needed; some GI side effects

2023|New England Journal of Medicine
PubMed

Community Outcomes

Community Data Coming Soon

Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!

Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.

Important Warnings

  • •Currently in Phase 3 trials — not yet FDA approved
  • •Expected side effects similar to other GLP-1 agonists (nausea, GI issues)
  • •Long-term safety data not yet available
  • •Only available through clinical trials currently
Sourcing, Diagnostic Bloodwork & Telehealth Pathways

Where to get Retatrutide, baseline labs & clinician oversight.

Full Retatrutide $/mg comparison →
50% OFF AUTO-APPLIED$4.17/mg net

Ascension Peptides (US Vials)

MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.

MZ Biolabs COA (Grade A)Claim 50% Off
Verified Vial SuppliersGrade A COA

SwissChems & Limitless Biotech

Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).

LABS & 503A CLINICS$199/yr Labs · Rx Consult

Superpower Labs & 503A Telehealth

Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.

Code:SPAMBASSADOR

Where to buy Retatrutide: best verified price

Prices checked Nov 11, 2026 · sorted by $/mg · RUO

  1. 1. Elite Research USA — $3.75/mg (60mg vial, sold as “ER-RT”, $225.00)
  2. 2. Ascension Peptides — $4.17/mg (30mg vial, sold as “R-30”, $125.00)
  3. 3. Peptyes — $5.00/mg (30mg vial, sold as “GLP-3 (R)” (vendor code name; compound per COA identity result), $150.00)

Where is the cheapest place to buy Retatrutide?

As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Elite Research USA at $3.75/mg (60mg vial, sold as “ER-RT”, $225.00). We compared 7 US suppliers with live, checked prices.

How much does Retatrutide cost per mg?

Verified US domestic prices currently range from $3.75/mg to $6.67/mg depending on supplier and vial size. Larger vials usually lower the $/mg.

How are these prices verified?

Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.

Is Retatrutide approved for human use?

Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.

All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet

FREE 1-PAGE PDF CHEAT SHEET

Peptide Reconstitution & U-100 Syringe Cheat Sheet

Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.

Unsubscribe anytime.Direct PDF Download

Related Peptides

Vendor vs vendor: price per mg

Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.

Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →

Common questions

How many peptides are in the database?

100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.

Where can I compare peptide prices?

Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.